Share on StockTwits

Analysts at Kepler Capital Markets started coverage on shares of Shire PLC (LON:SHP) in a research report issued to clients and investors on Thursday. The firm set a “buy” rating and a GBX 5,100 ($86.79) price target on the stock. Kepler Capital Markets’ target price suggests a potential upside of 12.91% from the stock’s current price.

Shire PLC (LON:SHP) traded up 0.44% during mid-day trading on Thursday, hitting GBX 4537.00. The stock had a trading volume of 2,378,917 shares. Shire PLC has a 1-year low of GBX 2016.35 and a 1-year high of GBX 4491.00. The stock’s 50-day moving average is GBX 3554. and its 200-day moving average is GBX 3179.37. The company’s market cap is £26.510 billion.

Several other analysts have also recently commented on the stock. Analysts at Cowen and Company reiterated an “outperform” rating on shares of Shire PLC in a research note on Wednesday. Separately, analysts at Bank of America raised their price target on shares of Shire PLC from GBX 3,859 ($65.67) to GBX 4,500 ($76.58) in a research note on Wednesday. They now have a “buy” rating on the stock. Finally, analysts at Shore Capital reiterated a “buy” rating on shares of Shire PLC in a research note on Wednesday. One equities research analyst has rated the stock with a sell rating, seven have assigned a hold rating, eighteen have assigned a buy rating and one has given a strong buy rating to the company’s stock. The stock has an average rating of “Buy” and a consensus target price of GBX 3,187.87 ($54.25).

Shire plc (LON:SHP) is a specialty biopharmaceutical company that focuses on meeting the needs of the specialist physician.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.